Compromised β-cell development and β-cell dysfunction in weanling offspring from dams maintained on a high-fat diet during gestation

Pancreas

Volumn 34, Issue 3, 2007, Pages 347-353

  Cerf, Marlon E ^a   Williams, Keith ^a   Chapman, Charna S ^a   Louw, Johan ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

cell; Glucokinase; Hyperglycemia; Hypoinsulinemia; Type 2 diabetes

Indexed keywords

GLUCOKINASE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL COUNT; CELL MATURATION; CELL SIZE; CELL VOLUME; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOINSULINEMIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; LACTATION; LIPID DIET; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; PROGENY;

ANIMALS; BLOOD GLUCOSE; DIETARY FATS; DNA PRIMERS; FEMALE; GLUCOKINASE; INSULIN-SECRETING CELLS; PANCREAS; PREGNANCY; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WEANING;

EID: 34247117762     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31802ee9ae     Document Type: Article

References (47)

1. Surwit RS, Feinglos MN, Rodin J, et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism. 1995;44:645-651.
2. Surwit RS, Kuhn CM, Cochrane C, et al. Diet-induced type II diabetes in C57BL/6J mice. Diabetes. 1988;37:1163-1167.
3. Cerf ME, Williams K, Nkomo XI, et al. Islet cell response in the neonatal rat after exposure to a high-fat diet during pregnancy. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1122-R1128.
4. Iwashita S, Kim YB, Miyamoto H, et al. Diurnal rhythm of plasma insulin and glucose in rats made obese by a high fat diet. Horm Metab Res. 1996;28:199-201.
5. Ahren B, Gudbjartsson T, Al-Amin AN, et al. Islet perturbations in rats fed a high-fat diet. Pancreas. 1999;18:75-83.
6. Kim Y, Iwashita S, Tamura T, et al. Effect of high-fat diet on the gene expression of pancreatic GLUT2 and glucokinase in rats. Biochem Biophys Res Commun. 1995;208:1092-1098.
7. Burcelin R, Crivelli V, Dacosta A, et al. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab. 2002;282:E834-E842.
8. Cerf ME, Muller CJ, Du Toit DF, et al. Hyperglycaemia and reduced glucokinase expression in weanling offspring from dams maintained on a high-fat diet. Br J Nutr. 2006;95:391-396.
9. Mulder H, Martensson H, Sundler F, et al. Differential changes in islet amyloid polypeptide (amylin) and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism. 2000;49:1518-1522.
10. Picarel-Blanchot F, Berthelier C, et al. Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat. Am J Physiol. 1996;271:E755-E762.
11. Movassat J, Saulnier C, Portha B. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus. Diabetes Metab. 1995;21:365-370.
12. Eriksson U, Swenne I. Diabetes in pregnancy: growth of the fetal pancreatic B cells in the rat. Biol Neonate. 1982;42:239-248.
13. Swenne I, Eriksson U. Diabetes in pregnancy: islet cell proliferation in the fetal rat pancreas. Diabetologia. 1982;23:525-528.
14. Kaung HL. Growth dynamics of pancreatic islet cell populations during fetal and neonatal development of the rat. Dev Dyn. 1994;200:163-175.
15. Bouwens L, Wang RN, De Blay E, et al. Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes. 1994;43:1279-1283.
16. Upchurch BH, Aponte GW, Leiter AB. Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development. 1994;120:245-252.
17. Siemelink M, Verhoef A, Dormans JA, et al. Dietary fatty acid composition during pregnancy and lactation in the rat programs growth and glucose metabolism in the offspring. Diabetologia. 2002;45:1397-1403.
18. Del Guerra S, Lupi R, Marselli L, et al. Functional and molecular defects of pancreatic islets in human type 2 diabetes. Diabetes. 2005;54:727-735.
19. Brissova M, Blaha M, Spear C, et al. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am J Physiol Endocrinol Metab. 2005;288:E707-E714.
20. Pick A, Clark J, Kubstrup C, et al. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat. Diabetes. 1998;47:358-364.
21. Donath MY, Gross DJ, Cerasi E, et al. Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes. 1999;48:738-744.
22. Poitout V, Robertson RP. Minireview: secondary beta-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology. 2002;143:339-342.
23. Skelly RH, Bollheimer LC, Wicksteed BL, et al. A distinct difference in the metabolic stimulus-response coupling pathways for regulating proinsulin biosynthesis and insulin secretion that lies at the level of a requirement for fatty acyl moieties. Biochem J. 1998;331:553-561.
24. Ruderman N, Prentki M. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov. 2004;3:340-351.
25. Prentki M, Corkey BE. Are the beta-cell signaling molecules malonyl-CoA and cystolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes. 1996;45:273-283.
26. Prentki M, Joly E, El-Assaad W, et al. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes. 2002;51:S405-S413.
27. El-Assaad W, Buteau J, Peyot ML, et al. Saturated fatty acids synergize with elevated glucose to cause pancreatic beta-cell death. Endocrinology. 2003;144:4154-4163.
28. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46:3-19.
29. Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest. 2002;32:35-45.
30. Porte D, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes. 2001;50:S160-S163.
31. Kaiser N, Yuli M, Uckaya G, et al. Dynamic changes in beta-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomys obesus: impact of glycemic control. Diabetes. 2005;54:138-145.
32. Matschinsky FM. Banting lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 1996;45:223-241.
33. Matschinsky FM. Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics. Diabetes. 2002;51:S394-S404.
34. Postic C, Shiota M, Magnuson MA. Cell-specific roles of glucokinase in glucose homeostasis. Recent Prog Horm Res. 2001;56:195-217.
35. Jorns A, Tiedge M, Ziv E, et al. Gradual loss of pancreatic beta-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time course of nutritionally induced type-2 diabetes in Psammomys obesus (sand rat). Virchows Arch. 2002;440:63-69.
36. Brooks SP, Lampi BJ. Effect of dietary fat on whole body fatty acid synthesis in weanling rats. J Nutr Biochem. 1999;10:291-298.
37. Savastano DM, Covasa M. Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr. 2005;135:1953-1959.
38. Fowden AL. Insulin deficiency: effects on fetal growth and development. J Paediatr Child Health. 1993;29:6-11.
39. Hattersley AT, Beards F, Ballantyne E, et al. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19:268-270.
40. Cha MC, Johnson JA, Hsu CY, et al. High-fat hypocaloric diet modifies carbohydrate utilization of obese rats during weight loss. Am J Physiol Endocrinol Metab. 2001;280:E797-E803.
41. Harris RB, Kor H. Insulin insensitivity is rapidly reversed in rats by reducing dietary fat from 40 to 30% of energy. J Nutr. 1992;122:1811-1822.
42. Armitage JA, Khan IY, Taylor PD, et al. Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals? J Physiol. 2004;561:355-377.
43. Buckley AJ, Keseru B, Briody J, et al. Altered body composition and metabolism in the male offspring of high fat-fed rats. Metabolism. 2005;54:500-507.
44. Gluckman PD, Hanson MA. The developmental origins of the metabolic syndrome. Trends Endocrinol Metab. 2004;15:183-187.
45. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res. 2004;56:311-317.
46. Gluckman PD, Hanson MA. Living with the past: evolution, development, and patterns of disease. Science. 2004;305:1733-1736.
47. Gluckman PD, Cutfield W, Hofman P, et al. The fetal, neonatal, and infant environments - the long-term consequences for disease risk. Early Hum Dev. 2005;81:51-59.